Aji Bio-Pharma 新闻稿 新闻稿 June 30, 2020 Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing 阅读更多 June 2, 2020 Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India 阅读更多 May 27, 2020 Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19 阅读更多 May 5, 2020 Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials 阅读更多 April 30, 2020 Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic 阅读更多 March 10, 2020 Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board 阅读更多 September 2, 2019 Information accompanying the revision of the consumption tax rate 阅读更多 August 29, 2019 Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India 阅读更多 April 9, 2019 Information on Service Brand Name Change 阅读更多 April 9, 2019 GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center 阅读更多 April 3, 2019 Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing 阅读更多 March 12, 2019 Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth 阅读更多 加载中…加载更多
